Literature DB >> 1362455

Adenosine but not an adenine nucleotide mediates tonic purinergic inhibition, as well as inhibition by glutamate, of noradrenaline release in rabbit brain cortex slices.

I von Kügelgen1, L Späth, K Starke.   

Abstract

A possible contribution of adenine nucleotides to the endogenous purinergic, A1-receptor-mediated inhibition of noradrenaline release was studied in rabbit occipito-parietal cortex slices. The slices were preincubated with [3H]-noradrenaline and then superfused and stimulated electrically, in most experiments by trains of 6 pulses/100 Hz. A few experiments were carried out in rat occipito-parietal cortex slices. The A1-purinoceptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 1-100 nmol/l) as well as the enzyme adenosine deaminase (0.1-10 U/ml) increased the electrically evoked overflow of tritiated compounds. The maximal increase was by about 85% for both DPCPX and adenosine deaminase. The increases obtained with maximally effective concentrations of DPCPX and adenosine deaminase were not additive. The alpha 1-adrenoceptor-selective agonist methoxamine (10 but not 1 mumol/l) reduced the evoked overflow. Its effect was antagonized by yohimbine 1 mumol/l but then not attenuated further by DPCPX 100 nmol/l. L-Glutamate (300 mumol/l-2.3 mmol/l) also reduced the evoked overflow of tritium. Its effect was not changed by yohimbine 1 mumol/l but greatly, and to the same extent, attenuated by DPCPX 100 nmol/l and adenosine deaminase 3 U/ml. Neither the N-methyl-D-aspartate (NMDA) receptor antagonist dizocilpine nor omission of Mg++ changed the inhibition by glutamate. Glutamate did not alter the basal efflux of tritium from rabbit cortex slices under any experimental condition. In contrast, glutamate (100 mumol/l and 1 mmol/l) caused an immediate, marked and transient acceleration of tritium outflow from rat occipitoparietal cortex slices (medium without Mg++).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1362455     DOI: 10.1007/bf00168742

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  37 in total

Review 1.  Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists.

Authors:  J C Watkins; P Krogsgaard-Larsen; T Honoré
Journal:  Trends Pharmacol Sci       Date:  1990-01       Impact factor: 14.819

Review 2.  Modulation of neurotransmitter release by presynaptic autoreceptors.

Authors:  K Starke; M Göthert; H Kilbinger
Journal:  Physiol Rev       Date:  1989-07       Impact factor: 37.312

Review 3.  Modulation of neurotransmission by purine nucleotides and nucleosides.

Authors:  B B Fredholm; P Hedqvist
Journal:  Biochem Pharmacol       Date:  1980-06-15       Impact factor: 5.858

4.  Evoked release of endogenous adenosine from rat cortical slices by K+ and glutamate.

Authors:  K Hoehn; T D White
Journal:  Brain Res       Date:  1989-01-23       Impact factor: 3.252

5.  Adenosine receptors mediating cyclic AMP production in the rat hippocampus.

Authors:  B B Fredholm; B Jonzon; E Lindgren; K Lindström
Journal:  J Neurochem       Date:  1982-07       Impact factor: 5.372

6.  N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. II. Evidence for functional cooperation and for coexistence on the same axon terminal.

Authors:  M Raiteri; B Garrone; A Pittaluga
Journal:  J Pharmacol Exp Ther       Date:  1992-01       Impact factor: 4.030

7.  Adenosine: an endogenous modulator of hippocampal noradrenaline release.

Authors:  R Jackisch; R Fehr; G Hertting
Journal:  Neuropharmacology       Date:  1985-06       Impact factor: 5.250

8.  Veratridine and other depolarizing agents counteract the inhibitory effect of Mg2+ ions on N-methyl-D-aspartate (NMDA)-induced noradrenaline release in vitro.

Authors:  K Fink; M Göthert; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-07       Impact factor: 3.000

9.  Stable adenine nucleotides inhibit [3H]-noradrenaline release in rabbit brain cortex slices by direct action at presynaptic adenosine A1-receptors.

Authors:  I von Kügelgen; L Späth; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000

10.  Endogenous adenosine release from hippocampal slices: excitatory amino acid agonists stimulate release, antagonists reduce the electrically-evoked release.

Authors:  F Pedata; M Pazzagli; G Pepeu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-11       Impact factor: 3.000

View more
  6 in total

1.  Presynaptic modulation by L-glutamate and GABA of sympathetic co-transmission in rat isolated vas deferens.

Authors:  Y W Kwan; M P Ngan; K Y Tsang; H M Lee; L A Chu
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

2.  Kainate receptors are involved in the glutamate-induced indirect, purinergic inhibition of [3H]-noradrenaline release in rabbit brain cortex.

Authors:  I von Kugelgen; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

3.  Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: contribution of P1- and P2-purinoceptors.

Authors:  K Kurz; I von Kügelgen; K Starke
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

4.  Methoxamine inhibits noradrenaline release through activation of alpha 1- and alpha 2-adrenoceptors in rat isolated kidney: involvement of purines and prostaglandins.

Authors:  C Bohmann; P Schollmeyer; L C Rump
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

5.  Ionotropic glutamate receptor types leading to adenosine-mediated inhibition of electrically evoked [3H]-noradrenaline release in rabbit brain cortex slices.

Authors:  I von Kügelgen; L Späth; K Starke
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

6.  Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex.

Authors:  I von Kügelgen; L Späth; K Starke
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.